TurtleTree obtains the world's first self-GRAS for animal-free lactoferrin, LF+™ now approved to commercialize in the U.S.
This regulatory milestone sets the stage for U.S. commercialization in Q4 2023. Using precision fermentation, TurtleTree expects profitability on LF+ in 2024 and will address global supply scarcity. SACRAMENTO, Calif. and SINGAPORE, Nov. 23, 2023...